BioCentury | Jul 30, 2018
Company News

Management Tracks: Abeona, BioDelivery

...Ltd. (Dublin, Ireland) hired Jesse Hall as CMO. He was an executive medical director at Ardea Biosciences Inc....
BioCentury | Jun 3, 2016
Company News

AstraZeneca continues to divest Zurampic rights

...royalties (see BioCentury Extra, April 26) . AZ gained Zurampic via its 2012 acquisition of Ardea Biosciences Inc....
BioCentury | May 2, 2016
Finance

Playing the primaries

...inhibitor to treat hyperuricemia associated with uncontrolled gout. AstraZeneca gained the asset when it acquired Ardea Biosciences Inc....
BioCentury | May 2, 2016
Company News

AstraZeneca, Ironwood deal

...upon FDA approval of the Zurampic/allopurinol combo. AZ gained Zurampic via its 2012 acquisition of Ardea Biosciences Inc....
BioCentury | Apr 27, 2016
Company News

Ironwood gets U.S. rights to AZ's Zurampic

...upon FDA approval of the Zurampic/allopurinol combo. AZ gained Zurampic via its 2012 acquisition of Ardea Biosciences Inc....
BioCentury | Feb 20, 2016
Company News

AZ's gout drug Zurampic gains EU approval

...12 ( SLC22A12 ; URAT1 ) inhibitor. AZ gained the drug via its acquisition of Ardea Biosciences Inc....
BioCentury | Dec 23, 2015
Company News

AZ's Zurampic gains FDA approval for gout

...Zurampic (see BioCentury Extra, Oct. 23) . AZ gained the drug via its acquisition of Ardea Biosciences Inc....
BioCentury | Oct 24, 2015
Company News

FDA panel backs<span class="*Red-type+bold"> AZ's gout therapy

...wanted to see additional safety data. AZ gained lesinurad through its $1.3 billion acquisition of Ardea Biosciences Inc....
BioCentury | Aug 19, 2015
Company News

FDA committee to discuss AZ's gout treatment

...to treat hyperuricemia associated with gout. Ardea Biosciences Inc. submitted the NDA; AstraZeneca plc (LSE:AZN; NYSE:AZN) acquired Ardea...
BioCentury | Oct 13, 2014
Company News

Conatus management update

...Infectious, Endocrine/Metabolic Hired: David Hagerty as EVP of clinical development, formerly SVP and CMO of Ardea Biosciences Inc....
Items per page:
1 - 10 of 336
BioCentury | Jul 30, 2018
Company News

Management Tracks: Abeona, BioDelivery

...Ltd. (Dublin, Ireland) hired Jesse Hall as CMO. He was an executive medical director at Ardea Biosciences Inc....
BioCentury | Jun 3, 2016
Company News

AstraZeneca continues to divest Zurampic rights

...royalties (see BioCentury Extra, April 26) . AZ gained Zurampic via its 2012 acquisition of Ardea Biosciences Inc....
BioCentury | May 2, 2016
Finance

Playing the primaries

...inhibitor to treat hyperuricemia associated with uncontrolled gout. AstraZeneca gained the asset when it acquired Ardea Biosciences Inc....
BioCentury | May 2, 2016
Company News

AstraZeneca, Ironwood deal

...upon FDA approval of the Zurampic/allopurinol combo. AZ gained Zurampic via its 2012 acquisition of Ardea Biosciences Inc....
BioCentury | Apr 27, 2016
Company News

Ironwood gets U.S. rights to AZ's Zurampic

...upon FDA approval of the Zurampic/allopurinol combo. AZ gained Zurampic via its 2012 acquisition of Ardea Biosciences Inc....
BioCentury | Feb 20, 2016
Company News

AZ's gout drug Zurampic gains EU approval

...12 ( SLC22A12 ; URAT1 ) inhibitor. AZ gained the drug via its acquisition of Ardea Biosciences Inc....
BioCentury | Dec 23, 2015
Company News

AZ's Zurampic gains FDA approval for gout

...Zurampic (see BioCentury Extra, Oct. 23) . AZ gained the drug via its acquisition of Ardea Biosciences Inc....
BioCentury | Oct 24, 2015
Company News

FDA panel backs<span class="*Red-type+bold"> AZ's gout therapy

...wanted to see additional safety data. AZ gained lesinurad through its $1.3 billion acquisition of Ardea Biosciences Inc....
BioCentury | Aug 19, 2015
Company News

FDA committee to discuss AZ's gout treatment

...to treat hyperuricemia associated with gout. Ardea Biosciences Inc. submitted the NDA; AstraZeneca plc (LSE:AZN; NYSE:AZN) acquired Ardea...
BioCentury | Oct 13, 2014
Company News

Conatus management update

...Infectious, Endocrine/Metabolic Hired: David Hagerty as EVP of clinical development, formerly SVP and CMO of Ardea Biosciences Inc....
Items per page:
1 - 10 of 336